维普中文期刊产品整合服务
108篇 您的检索式:作者名="Lord V"
    题名 作者 年代 出处 被引量
1MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett's esophagus显示文摘AIM To investigate the micro RNA expression profile in esophageal neosquamous epithelium from patients who had undergone ablation of Barrett's esophagus.METHODS High throughput screening using Taq Man~ Array Human Micro RNA quantitative PCR was used to determine expression levels of 754 micro RNAs in distal esophageal mucosa(1 cm above the gastro-esophageal junction) from 16 patients who had undergone ablation of non-dysplastic Barrett's esophagus using argon plasma coagulation vs pretreatment mucosa, posttreatment proximal normal non-treated esophageal mucosa, and esophageal mucosal biopsies from 10 controls without Barrett's esophagus. Biopsies of squamous mucosa were also taken from 5 cm above the pre-ablation squamo-columnar junction. Predicted m RNA target pathway analysis was used to investigate the functional involvement of differentially expressed micro RNAs.RESULTS Forty-four micro RNAs were differentially expressed between control squamous mucosa vs post-ablation neosquamous mucosa. Nineteen micro RNAs were differentially expressed between post-ablation neosquamous and post-ablation squamous mucosa obtained from the more proximal non-treated esophageal segment. Twelve microRNAs were differentially expressed in both neosquamous vs matched proximal squamous mucosa and neosquamous vs squamous mucosa from healthy patients. Nine micro RNAs(mi R-424-5p, mi R-127-3p, mi R-98-5p, mi R-187-3p, mi R-495-3p, mi R-34c-5p, mi R-223-5p, mi R-539-5p, mi R-376a-3p, mi R-409-3p) were expressed at higher levels in post-ablation neosquamous mucosa than in matched proximal squamous and healthy squamous mucosa. These micro RNAs were also more highly expressed in Barrett's esophagus mucosa than matched proximal squamous and squamous mucosa from controls. Target prediction and pathway analysis suggests that these micro RNAs may be involved in the regulation of cell survival signalling pathways. Three micro RNAs(mi R-187-3p, mi R-135b-5p and mi R-31-5p) were expressed at higher levels in postablation neosquamous mucosa than in matched proximal squamous and healthy squamous mucosa. These mi RNAs were expressed at similar levels in preablation Barrett's esophagus mucosa, matched proximal squamous and squamous mucosa from controls. Target prediction and pathway analysis suggests that these micro RNAs may be involved in regulating the expression of proteins that contribute to barrier function.CONCLUSION Neosquamous mucosa arising after ablation of Barrett's esophagus expresses micro RNAs that may contribute to decreased barrier function and micro RNAs that may be involved in the regulation of survival signaling pathways.Loveena Sreedharan George C Mayne David I Watson Timothy Bright Reginald V Lord Alfiya Ansar Tingting Wang Jakob Kist David StJ Astill Damian J Hussey 2017World Journal of Gastroenterology2017,23,30:3
2Percutaneous sclerotherapy for lymphatic malformations:a retrospective analysis of patient-evaluated improvement显示文摘Alomari A I Karian V E Lord D J 2006J Vasc Interv Radiol2006,17,10:1
3Effects of child characteristics on the autism diagnostic interview-revised:implications for use of scores as a measure of ASD severity 显示文摘Hus V Lord C 2013J Autism Dev Disord2013,43,2:1
4S-100 positive cells in human arterial intima and in atherosclerotic lesions 显示文摘Bobryshev Y V Lord R S 1995Cardiovasc Res1995,29,5:1
5DNA repair and cisplatin resistance in non-small-cell lung cancer显示文摘Rosell R Lord R V Taron M 2002Lung Cancer2002,38,3:1
6DNA repair and cisplatin resistance in non-small cell lung cancer显示文摘Rosell R Lord R V Taron M 2002Lung Cancer2002,38,3:1
7Field study of vaccination of cattle with Brucella abortus strains RBS1 and 19 under high and low disease prevalence显示文摘Lord V R Schurig G G Cherwonogrodzky J W 1998Am J Vet Res1998,59,8:1
8Emergency physician recognition of adverse drug-related events in elder patients presenting to an emergency department显示文摘Hohl CM Robitaille C Lord V 2005Acad Emerg Med2005,12,3:1
9LowERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung can-cer显示文摘LORD R V BRABENDER J GANDARA D 2002Clin Cancer Res2002,8,7:1
10Low ERCCI expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung Cancer显示文摘LORD R V BRABENDER J GANDARA D 2002Clin Cancer Res2002,8,7:1
11Mapping of vascular dendritic cells in atherosclerotie arteries suggests their involvement in local immuneinflammatory reactions 显示文摘Bobryshev Y V Lord R S 1998Cardiovasc Res1998,37,3:1
12Benthic ostracods and deep water-masses in the Atlantic Ocean 显示文摘Dingle R V Lord A R 1990Palaeogeography Palaeoclimatology Pataeoecology1990,80,34:1
13Co-accumulation of dendritic cells and natural killer T cells within rupture-prone regions in human atherosclerotic plaques显示文摘Bobryshev Y V Lord RSA 2005J Histochem Cytochem2005,53,6:1
14Granzyme B:a natural born killer显示文摘Lord S J Rajotte R V Korbutt G S 0,,01:1
15T-bet, a Thl transcription factor regulates the expression of Tim-3 显示文摘Anderson AC Lord GM Dardalhon V 2010Eur J Immuno12010,40,:1
16DNA repair and cisplatin resistance in non-small-cell lung cancer显示文摘Rosell R lord R V Taren M 2002Lung Cancer2002,38,4:1
17Clustering of dendritic cells in athero-prone areas of the aorta显示文摘Lord R S Bobryshev Y V 1999Atherosclerosis1999,146,1:1
18Low ERCC 1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell Lung cancer 显示文摘Reginald V Lord N Brabender J 2002Clin Cancer Res2002,8,7:1
19Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenoearcinoma显示文摘Kawakami K Brabender J Lord R V Groshen S Greenwald B D Krasna M J 2000J Natl Cancer Inst2000,92,:1
20DNA repair and cisplatin resistance in non-small-cell lung cancer 显示文摘Rosell R Lord R V Taron M 2002Lung Cancer2002,38,3:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费